These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24068317)

  • 1. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    BMC Womens Health; 2012 May; 12():12. PubMed ID: 22569005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
    Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
    Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.
    O'Shea R; Meany M; Carroll C; Cody N; Healy D; Green A; Lynch SA
    J Genet Couns; 2016 Jun; 25(3):422-31. PubMed ID: 26407988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.
    Schlich-Bakker KJ; Ausems MG; Schipper M; Ten Kroode HF; Wárlám-Rodenhuis CC; van den Bout J
    Breast Cancer Res Treat; 2008 Jun; 109(3):507-14. PubMed ID: 17674198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study.
    Han SA; Kim SW; Kang E; Park SK; Ahn SH; Lee MH; Nam SJ; Han W; Bae YT; Kim HA; Cho YU; Chang MC; Paik NS; Hwang KT; Kim SJ; Noh DY; Choi DH; Noh WC; Kim LS; Kim KS; Suh YJ; Lee JE; Jung Y; Moon BI; Yang JH; Son BH; Yom CK; Kim SY; Lee H; Jung SH;
    Fam Cancer; 2013 Mar; 12(1):75-81. PubMed ID: 23131904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
    Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
    Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
    Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
    Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
    BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30.
    Brunstrom K; Murray A; McAllister M
    J Genet Couns; 2016 Feb; 25(1):90-100. PubMed ID: 25983051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
    Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
    Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.